Acasti Pharma Cash Flow - Annual (NASDAQ:ACST)

Add to My Stocks
$0.57 $0.01 (1.79%) ACST stock closing price Sep 20, 2018 (Closing)

The Acasti Pharma cash flow statement helps investors understand how well the company is managing its cash flows. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about Acasti Pharma profits and Acasti Pharma debt. Acasti Pharma saw a cash impact of $- from the buyback of ACST shares. The cash flow statement helps in the Acasti Pharma stock analysis by providing more information for evaluating changes in assets, liabilities and equities. Acasti Pharma had an outflow of $-3.6M from operating activities, $-0.01M spend due to financing activities, and $2.69M inflow due to investing activities for 2016.

View details of Acasti Pharma cash flows for latest & last 10 financial years
show more
Fiscal year is Jan - Dec2016201520142013
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow1.38M1.35M1.56M1.28M
Net Increase (Decrease) in Assets Liabilities--1.49M2.43M
Cash From (used in) Discontinued Operations----
Other Adjustments Net--2.11M-7.74M2.99M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-1.33M-0.16M-0.03M-
Acquisition Disposition of Subsidiaires----
Increase (Decrease) in Investments3.94M6.4M5.07M2.64M
Other Cash Inflow (Outflow) from Investment Activities---0.01M-
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares----
Issuance (Repayment) of Debt Securities----
Increase (Decrease) in Bank & Other Borrowings----
Payment of Dividends & Other Cash Distributions----
Other Cash from (used by) Financing Activities-0.01M---0.03M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year2.28M--1.15M
Cash & Equivalents at Year End1.36M3.59M1.63M2.72M
All figures in USD. M: Millions of USD, B: Billions of USD.

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Acasti Pharma stock price history and Acasti Pharma stock comparison chart inevitably reflect its cash flow situation.

  • Acasti Pharma saw a negative change in Net Change in Cash and Cash Equivalents of $-0.91M in 2016. Apart from the Acasti Pharma stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • The cash generated from the core business or operations was a negative at $-3.6M for Acasti Pharma in the latest 2016. For an internet company, this would include all those activities which are involved in eventually selling advertisement space on its website or any online service.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $2.69M for ACST stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $-0.01M for Acasti Pharma.

Key Financial Ratios For Acasti Pharma Cash Flow

FCF margin